LianBio
LIANY· OTC
LIANYLianBio
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001831283-23-000110
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Net Income | -$21.62M | -$42.39M | -$100.43M | -$2.51M |
| EPS Diluted | -$0.20 | -$0.39 | -$4.90 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
LianBio · CIK 1831283 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
